Paxneury
Active substance: guanfacine
guanfacine hydrochloride
Centralised EU authorisationActive
Marketing holder: Neuraxpharm Pharmaceuticals S.L.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
| US 123 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c5-8961-7a1c-9f10-51b4c1fb6666;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2962-7136-a9bc-70224f9fc4e4,01a1208c-2b16-7263-adc0-eff9ca856390,01a1208c-2b45-705a-a201-4203b864e1bd,01a1208c-2e6e-754c-b8a3-3dbd1b5952a9,01a1208c-30b7-7eaf-9f56-c1cb65350328;count=123 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/006312
- Registration status
- Active
- ATC code
- C02AC02
Sources
- product · EMA · EMEA/H/C/006312 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006312 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006312 · Verified 2026-10-09